Pages that link to "Q42257506"

The following pages link to Prognostic implication of TIM-3 in clear cell renal cell carcinoma (Q42257506):

Displaying 20 items.

• The potential of radiotherapy to enhance the efficacy of renal cell carcinoma therapy (Q26783291) (← links)
• Tim-3 and its role in regulating anti-tumor immunity (Q33909020) (← links)
• Inhibitory Receptors Beyond T Cell Exhaustion. (Q35783318) (← links)
• Up-regulation of Tim-3 is associated with poor prognosis of patients with colon cancer (Q36014245) (← links)
• TIM-4 promotes the growth of non-small-cell lung cancer in a RGD motif-dependent manner (Q36750950) (← links)
• Interference with Tim-3 protein expression attenuates the invasion of clear cell renal cell carcinoma and aggravates anoikis. (Q37722095) (← links)
• Clinical and molecular prognostic and predictive biomarkers in clear cell renal cell cancer (Q38294622) (← links)
• T cell immunoglobulin domain and mucin domain-3 as an emerging target for immunotherapy in cancer management (Q38912251) (← links)
• Systematic evaluation of multiple immune markers reveals prognostic factors in ovarian cancer (Q39547277) (← links)
• Tim-3 Up-regulation in Patients with Gastric Cancer and Peptic Ulcer Disease (Q40238354) (← links)
• Low TIM3 expression indicates poor prognosis of metastatic prostate cancer and acts as an independent predictor of castration resistant status (Q41488394) (← links)
• Molecular and clinical characterization of TIM-3 in glioma through 1,024 samples (Q42777737) (← links)
• Tumor cell-intrinsic Tim-3 promotes liver cancer via NF-κB/IL-6/STAT3 axis (Q49957691) (← links)
• Galectin-9 predicts postoperative recurrence and survival of patients with clear-cell renal cell carcinoma. (Q53603499) (← links)
• Galectin-9 increases Tim-3 dendritic cells and CD8 T cells and enhances antitumor immunity via galectin-9-Tim-3 interactions. (Q55285607) (← links)
• Profiling Immune Escape in Hodgkin's and Diffuse large B-Cell Lymphomas Using the Transcriptome and Immunostaining (Q58582618) (← links)
• Differential expression of TIM-3 between primary and metastatic sites in renal cell carcinoma (Q60912351) (← links)
• [Prognostic relevance of TIM3 in renal cell carcinoma] (Q90323634) (← links)
• TIM-3 in endometrial carcinomas: an immunotherapeutic target expressed by mismatch repair-deficient and intact cancers (Q92708769) (← links)
• Vaginal microbiota, genital inflammation, and neoplasia impact immune checkpoint protein profiles in the cervicovaginal microenvironment (Q98503965) (← links)